![]() |
|
|||||||
| Public Companies to Watch Public Companies users are watching but are not invested in |
![]() |
|
|
Thread Tools | Display Modes |
|
#1
|
||||
|
||||
|
BUSINESS SUMMARY
Hythiam, Inc., a development stage healthcare services management company, engages in the research, development, licensing, and commercialization of physiological treatment protocols for the treatment of alcoholism and other substance dependencies in the United States. The company offers HANDS Protocols for use by healthcare providers to treat patients diagnosed with dependencies on alcohol, cocaine, methamphetamine, and other addictive stimulants, as well as combinations of these drugs. Its HANDS Protocols also provide a maintenance program that includes medications and incentives for patients to continue with their recovery process through individualized continuing care programs. The company also offers administrative services to assist physicians and facilities with staff education, clinical services, marketing and sales support, and outcomes tracking methodologies for data analysis. Hythiam is based in Los Angeles, California. Share Statistics Average Volume (3 month)3: 338,542 Average Volume (10 day)3: 842,857 Shares Outstanding: 39.58M Float: 19.21M % Held by Insiders4: 76.38% % Held by Institutions4: 7.30% Shares Short (as of 10-Feb-06)3: 2.10M Short Ratio (as of 10-Feb-06)3: 10.2 Short % of Float (as of 10-Feb-06)3: 8.20% Shares Short (prior month)3: 1.37M Balance Sheet Total Cash (mrq): 47.00M Total Cash Per Share (mrq): 1.188 Total Debt (mrq): 0 Total Debt/Equity (mrq): 0 Stock Price History Beta: 2.6 52-Week Change3: 5.06% S&P500 52-Week Change3: 10.97% 52-Week High (28-Mar-06)3: 9.15 52-Week Low (17-Nov-05)3: 4.26 50-Day Moving Average3: 6.75 200-Day Moving Average3: 6.21 In analyzing the company, look at the low amount of shares outstanding, the low float, zero debt, 47 million capital on hand, the doubling of volume over the last 10 trading days and decent short interest ratio, coupled by the business that they are in and this has the potential for some explosive parabolic price appreciation. JBA pointed out this stock to me and I said I would do some due diligence. I have and I feel that this has the very good potential for a $15 target to be achieved over a very reasonable amount of time. http://stockcharts.com/gallery/?hytm News:http://biz.yahoo.com/bw/060327/20060327005476.html?.v=1 Hythiam Shares Rise on Favorable Data From Prometa Addiction Rehabilitation Study http://biz.yahoo.com/ap/060327/hythiam_mover.html?.v=1 I would feel comfortable owning this here and definately be a buyer on any pullbacks or profit taking. This is rudementary analysis compared to what I was paid to do at Prudential. Please do your own due diligence prior to purchasing shares in any company and have an exit strategy set, prior to buying and when the stock price hits your target to sell and don't look back. You can see jba about this company as I'm sure he'd he would be happy to extoll the virtues of it to you. PL1 on the Mark ~ ~![]() |
|
#2
|
||||
|
||||
|
HYTM
Friday 3:42 est $7.77+.45 High 7.79 low 7.35 199,786 shrs
__________________
Mel |
![]() |
| Thread Tools | |
| Display Modes | |
|
|